GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

VirExit Technologies VXIT · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About VirExit Technologies

Its shares trade under the ticker VXIT. It has been listed since 28 April 2016. In the fiscal year to 31 August 2022, it reported revenue of $2,199 and a net loss of $847,126. At that date it held total assets of $7,014 and shareholders' equity of −$3.6m.

VirExit Technologies, Inc. operates as a renewable energy company, which engages in incubating franchise business concepts designed to affect the individual, community, and local economy in rural and peri-urban areas across the globe. The company is headquartered in Richland, Washington. The company went IPO on 2016-04-28. The firm is also focused on creating a primary sales and marketing platform as a vertical online marketplace to provide a single source for buyers and sellers of protective products and services. Its products include disinfectant cleaners, antiviral medications, personal protective equipment (PPE) and sterilization systems. Its brands include VirExit(r) and VirExit.com. Its Lexian product is an Ultraviolet-C-based device which operates by optically diffusing energy over a specified area to disable viruses and bacteria.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Listed since
28 Apr 2016
Website
virexit.biz ↗

Leadership

Pay as last reported

  • Mr. John LowtherChairman of the Board, President, since 2013$180,000
  • James KatzaroffChief Executive Officer
  • Bruce JolliffChief Financial Officer
  • Mr. David CroomChief Operating Officer
  • Mr. Brooke GreenwaldChief Marketing Officer
  • Mr. George CritzDirector, since 2013$120,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • VirExit Technologies Inc. offers disinfectant cleaners and antiviral medications globally.
  • Lexian UV-C device provides effective virus and bacteria disinfection in various settings.
  • VirExit.com serves as a primary online marketplace for protective products and services.

Weaknesses

  • VirExit Technologies Inc. focuses on rural and peri-urban areas with limited market reach.
  • The company's IPO in 2016 may indicate early-stage financial constraints.
  • Lexian product is limited to UV-C technology without broader applications.

Opportunities

  • Expanding into the global Health Care sector for disinfection solutions.
  • Growing demand for PPE in the Information Technology industry.
  • Increasing market for sterilization systems in the Consumer Discretionary segment.

Threats

  • Competition from established disinfectant brands in the US market.
  • Regulatory challenges in the Financials sector for online marketplaces.
  • Economic downturns affecting rural and peri-urban community investments.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.